User profiles for Balazs Murnyak

Balazs Murnyak

High-Throughput Genomics / Huntsman Cancer Institute
Verified email at utah.edu
Cited by 506

[HTML][HTML] Immunohistochemical correlates of TP53 somatic mutations in cancer

B Murnyák, T Hortobágyi - Oncotarget, 2016 - ncbi.nlm.nih.gov
Despite controversy on the correlation between p53 accumulation and TP53 mutational
status, ihas long been used as a surrogate method for mutation analysis. The aim of our study …

[HTML][HTML] Pathophysiology of meningioma growth in pregnancy

T Hortobágyi, J Bencze, B Murnyák, MC Kouhsari… - Open …, 2017 - degruyter.com
Meningioma is among the most frequent brain tumours predominantly affecting elderly women.
Epidemiological studies have shown that at the age of fertility the incidence is relatively …

[HTML][HTML] PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma

B Murnyák, MC Kouhsari, R Hershkovitch, B Kálmán… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Overexpression of PARP1 exists in various cancers, including glioblastoma (GBM). Although
PARP1 inhibition is a promising therapeutic target, no comprehensive study has addressed …

[HTML][HTML] Epigenetics of meningiomas

B Murnyák, L Bognár, Á Klekner… - BioMed research …, 2015 - hindawi.com
Meningiomas account for one-third of all adult central nervous system tumours and are divided
into three WHO grades. In contrast to the relatively well characterized genetic alterations, …

[HTML][HTML] Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma

B Murnyak, LE Huang - Cells, 2021 - mdpi.com
Since the initial discovery of recurrent isocitrate dehydrogenase 1 (IDH1) mutations at
Arg132 in glioma, IDH1 hotspot mutations have been identified in cholangiocarcinoma, …

Molecular subgroups of glioblastoma–an assessment by immunohistochemical markers

Á Nagy, F Garzuly, G Padányi, I Szűcs… - Pathology & Oncology …, 2019 - Springer
Comprehensive molecular characterization of and novel therapeutic approaches to glioblastoma
have been explored as a result of advancements in biotechnologies. In this study, we …

Poly (ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas

T Csonka, B Murnyák, R Szepesi, A Kurucz… - Folia …, 2014 - termedia.pl
Meningiomas are one of the most frequent intracranial tumours, with 13 histological types and
three grades according to the 2007 WHO Classification of Tumours of the Central Nervous …

Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence

T Csonka, B Murnyák, R Szepesi, J Bencze… - Folia …, 2016 - termedia.pl
Although tumour recurrence is an important and not infrequent event in meningiomas, predictive
immunohistochemical markers have not been identified yet. The aim of this study was to …

Molecular pathology of meningiomas

B Murnyak, T Csonka, T Hortobagyi - Ideggyogyaszati Szemle, 2015 - europepmc.org
Meningiomas represent nearly one-third of all adult primary brain tumours. According to
their clinical and histologic appearance, they can be divided into WHO grades I-III. Almost 90% …

Haemorrhagic transformation in ischaemic stroke is more frequent than clinically suspected–A neuropathological study

R Szepesi, Á Csokonay, B Murnyák… - Journal of the …, 2016 - Elsevier
Objectives The vast majority of literature on the frequency of the haemorrhagic transformation
of ischaemic stroke is based on imaging studies. The purpose of the present study was to …